Immune GES for macrophages, myeloid, antigen presentation machinery (APM), NK or CD8 T cells were associated with either ongoing response, EFS and/or DOR (none of the signatures associated consistently with all three efficacy metrics), suggesting that enrichment of select tumor immune infiltrates might be a factor supporting SOC responses. The gene discussed is UBXN11; the disease is neoplasm.